MedPath

Oxyla

Brand Name: Oxyla

Generic Name: Oxytocin

Active
Registration Number

DR-XY45566

Dosage Form

Solution for Injection (I.M./I.v.)

Issuance Date

October 1, 2021

Expiry Date

August 19, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength10 I.U./ mL
PackagingType I (borosilicate) Clear Glass Ampoule in 1 mL (net content). Box of 10 ampoules.

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Oxytocic
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

OxytocinActive
Monograph: Oxytocin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform